Regulative Loop between β-catenin and Protein Tyrosine Receptor Type γ in Chronic Myeloid Leukemia

Area of Science:

• Oncology
• Molecular Biology
• Hematology

Background:

• Protein tyrosine phosphatase receptor type γ (PTPRG) acts as a tumor suppressor gene.
• PTPRG is frequently down-regulated in Chronic Myeloid Leukemia (CML) via promoter hypermethylation.
• β-catenin (CTNNB1) is crucial for Leukemic Stem Cell (LSC) maintenance and CML progression.

Purpose of the Study:

• To elucidate the antagonistic regulatory relationship between PTPRG and β-catenin in CML.
• To investigate the impact of PTPRG on BCR-ABL1 activation and β-catenin expression.
• To explore the role of DNA methyltransferase 1 (DNMT1) in PTPRG regulation.

Main Methods:

• Investigated PTPRG inhibition effects on BCR-ABL1 and β-catenin.
• Assessed PTPRG's ability to dephosphorylate β-catenin.
• Correlated β-catenin expression with DNMT1 in PTPRG-negative CML cells.
• Examined PTPRG and β-catenin phosphorylation in primary CML samples.

Main Results:

• PTPRG inhibition activates BCR-ABL1 and modulates β-catenin expression.
• PTPRG dephosphorylates β-catenin, leading to its degradation.
• Increased β-catenin in PTPRG-negative CML correlates with DNMT1 overexpression.
• PTPRG re-expression occurs upon DNMT1 inhibition or down-regulation.

Conclusions:

• A novel regulatory loop between PTPRG and β-catenin in CML is identified.
• Imbalance in this PTPRG-β-catenin axis influences CML cell proliferation.
• PTPRG plays a critical role in regulating BCR-ABL1 and β-catenin phosphorylation in CML.